Catalina Capital Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,264
Closed -$541K 186
2025
Q1
$541K Sell
3,264
-4,867
-60% -$762K 0.35% 60
2024
Q4
$1.18M Buy
8,131
+33
+0.4% +$5.11K 0.39% 49
2024
Q3
$1.31M Buy
8,098
+1,473
+22% +$235K 0.44% 46
2024
Q2
$968K Sell
6,625
-1,524
-19% -$227K 0.36% 58
2024
Q1
$1.29M Buy
8,149
+4,309
+112% +$686K 0.54% 39
2023
Q4
$602K Buy
+3,840
New +$589K 0.4% 48

Other funds holding JNJ

Catalina Capital Group's JNJ Position: Q2 2025 in Review

Catalina Capital Group sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 3,264 shares — an estimated $541K sold.

Catalina Capital Group first reported a position in JNJ in Q4 2023 and held it in 6 quarters. The position peaked at $1.31M in Q3 2024. 4,084 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Catalina Capital Group reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Catalina Capital Group sold 3,264 Johnson & Johnson shares in Q2 2025, an estimated $541K.
  • Catalina Capital Group first reported a position in Johnson & Johnson in Q4 2023 and held it in 6 quarters.
  • Catalina Capital Group's Johnson & Johnson position peaked at $1.31M in Q3 2024.
  • 4,084 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Catalina Capital Group's 13F filing for Q2 2025, filed 21 Jul 2025.